Intravenous thrombolysis for specific brain strokes
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a clot-busting drug given through a vein can help people with certain types of deep brain strokes that happen in small arteries. It looks at patients who can be treated within 24 hours of symptoms starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had a stroke caused by a blocked blood vessel deep in the brain (not a large artery).
- You must have a brain MRI that shows a specific pattern of damage in certain small arteries (like the lenticulostriate artery, the paramedian pontine artery, or the anterior choroidal artery).
- The stroke must not be from a blood clot traveling from the heart or from a major artery blockage (50% or more).
- You must be able to receive treatment within 24 hours of when your stroke symptoms started.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a clot-busting drug (rt-PA) or a combination of two blood thinners (DAPT) works better for people having a small stroke caused by a blocked tiny artery in the brain. It aims to find the safest and most effective treatment within the first few hours after symptoms start.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
This trial tests a new clot-busting medicine called tenecteplase, given directly into the blood vessel in the brain, to treat strokes caused by a blockage in a medium-sized artery. The goal is to see if it can help restore blood flow and reduce disability, especially for patients who can be treated within 24 hours of stroke onset.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial tests whether tenecteplase (a clot-busting medication) can help patients who have had a stroke within 4.5 to 9 hours and show a specific pattern on brain MRI called DWI-FLAIR mismatch, which suggests the brain tissue may still be salvageable.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.